SINT (SINTX Technologies) 5-Year RORE % : -47.99% (As of Mar. 2026)


SINT SINTX Technologies Inc SINT
23 GF Score
Price $1.88
GF Value $0.15
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SINTX Technologies 5-Year RORE %?

SINTX Technologies SINT +0.75% 23 5-Year RORE % is -47.99 as of Mar. 2026. GuruFocus rates SINT with a GF Score™ of 23/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 706 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 83.85% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. SINTX Technologies's 5-Year RORE % for the quarter that ended in Mar. 2026 was -47.99%.

The industry rank for SINTX Technologies's 5-Year RORE % or its related term are showing as below:

SINT's 5-Year RORE % is ranked worse than
83.85% of 706 companies
in the Medical Devices & Instruments industry
Industry Median: -5.03 vs SINT: -47.99

SINTX Technologies  (NAS:SINT) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


SINTX Technologies 5-Year RORE % Related Terms


SINTX Technologies 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for SINTX Technologies's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SINTX Technologies 5-Year RORE % Chart

SINTX Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.69 -91.81 -68.42 -59.31 -42.16

SINTX Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.91 -32.89 -36.28 -42.16 -47.99

SINT vs ALRTF, CODX, PMI: 5-Year RORE % Comparison

For the Medical Devices subindustry, SINTX Technologies's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SINTX Technologies 5-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's 5-Year RORE % falls into.


SINT
23GF Score
SINTX Technologies Inc SINT
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SINTX Technologies 5-Year RORE % Calculation

SINTX Technologies's 5-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -5.06--8484 )/( -17668.61-0 )
=8478.94/-17668.61
=-47.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of -47.99 mean?
SINTX Technologies (SINT) has a 5-Year RORE % of -47.99 as of Mar. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on SINTX Technologies and its competitors. According to the industry distribution chart, SINTX Technologies ranks #592 out of 706 companies in the Medical Devices & Instruments industry, placing it in the top 83.9%.
Is SINTX Technologies' 5-Year RORE % too high?
SINTX Technologies' current 5-Year RORE % is -47.99. Based on the distribution chart, SINTX Technologies ranks #592 out of 706 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' 5-Year RORE % compare to ALRTF and CODX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #592 out of 706 companies for 5-Year RORE %. This places SINTX Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Medical Devices & Instruments company?
A good 5-Year RORE % depends on the Medical Devices & Instruments industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on SINTX Technologies and its competitors. SINTX Technologies's current 5-Year RORE % is -47.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.88 — trading 1150% above its estimated fair value. The current 5-Year RORE % is -47.99. SINTX Technologies' overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For SINTX Technologies (SINT), the current 5-Year RORE % is -47.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SINTX Technologies (SINT) Overvalued in 2026?

Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued. The current stock price of $1.88 is trading 1150% above its estimated GF Value™ of $0.15. GuruFocus considers SINTX Technologies to be Significantly Overvalued.

Key valuation signals for SINT:

  • 5-Year RORE %: -47.99
  • GF Value™: $0.15 vs. price of $1.88 (1150% above fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SINTX Technologies Business Description

Other Exchanges 0A8S:UK
Address 1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
23GF Score

Get the complete analysis for SINT

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price
$0.15
GF Value